STOCK TITAN

AKANDA CORP - AKAN STOCK NEWS

Welcome to our dedicated page for AKANDA news (Ticker: AKAN), a resource for investors and traders seeking the latest updates and insights on AKANDA stock.

About Akanda Corp

Akanda Corp (NASDAQ: AKAN) is an international medical cannabis and wellness company dedicated to improving lives through high-quality, affordable cannabis-based products. Headquartered in London, UK, Akanda operates across the cannabis value chain, encompassing cultivation, manufacturing, and distribution. With a mission to provide safe and reliable cannabis solutions, the company focuses on medical-grade cannabis and wellness products, adhering to stringent regulatory standards and leveraging innovative technologies.

Core Business Segments

Cultivation: Akanda's cultivation activities are centered in Portugal through its subsidiary Holigen, which operates an EU GMP-certified indoor grow facility. This facility ensures compliance with European Union Good Manufacturing Practices, enabling the production of premium medical-grade cannabis for the European and international markets.

Distribution: In the United Kingdom, Akanda's subsidiary, CanMart Ltd, is a fully licensed importer and distributor of Cannabis-Based Products for Medicinal Use (CBPMs). CanMart supplies pharmacies and clinics while also offering third-party import and distribution services for Schedule 2 products, including CBPMs.

Corporate: Akanda's corporate segment manages administrative functions and strategic initiatives, including partnerships, acquisitions, and technological advancements to support the broader group.

Technological Innovation

Recognizing the transformative potential of technology, Akanda is actively exploring blockchain and artificial intelligence (AI) applications within the cannabis industry. Blockchain technology enhances supply chain transparency by securely tracking products from cultivation to sale, while AI-driven algorithms optimize product customization and strain development. These innovations position Akanda at the forefront of the cannabis-tech convergence.

Strategic Partnerships and Market Position

Akanda has established strategic alliances with industry leaders such as Cookies, Cansativa Group, and Cellen Life Sciences. These partnerships bolster its seed-to-patient supply chain and expand its market reach across Europe and North America. Additionally, Akanda's entry into the Canadian and German markets underscores its commitment to growth and global market leadership.

Commitment to Sustainability and Compliance

Akanda prioritizes sustainability and compliance in its operations. Its EU GMP-certified facilities and adherence to local and international regulations ensure product quality and safety. The company's focus on sustainable business practices aligns with its mission to deliver value to consumers and stakeholders alike.

Future Outlook

With a strategic emphasis on innovation, market expansion, and regulatory compliance, Akanda is well-positioned to capitalize on the growing global cannabis market. The company's integration of advanced technologies and its focus on medical and wellness applications highlight its commitment to shaping the future of the cannabis industry.

Rhea-AI Summary
Akanda Corp. (AKAN) announces integration with META for social shopping on Facebook and Instagram, expanding Canmart's reach. Canmart plans to showcase vendor products through shoppable content on social media, enhancing user experience and audience engagement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.09%
Tags
none
-
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) aims to integrate technology like Bitcoin, Blockchain, and AI into the cannabis industry to address banking challenges, quality control, and supply chain issues. The company plans to leverage cryptocurrencies for banking solutions and blockchain for transparent supply chain management. Additionally, Akanda is exploring AI applications to optimize cannabis strains and customize plant growth. With a strong financial position from a recent public offering, the company intends to expand its global presence through its UK subsidiary Canmart and the Gabriola Green Project in Canada.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.09%
Tags
AI
-
Rhea-AI Summary
Akanda Corp. (AKAN) enters into an underwriting agreement with Univest Securities, for a public offering of Common Shares and Pre-Funded Warrants, raising $5,000,000. The net proceeds will be used for various purposes including capital expenditures, working capital, and acquisitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.09%
Tags
Rhea-AI Summary
Akanda Corp. announces a firm commitment underwriting agreement with Univest Securities, for a public offering of common shares, estimating gross proceeds of $5,000,000.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-32.38%
Tags
-
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) announces the sale of its Portuguese subsidiary, RPK BioPharma, to Somai Pharmaceuticals for $2 million. The deal includes a $500,000 escrow deposit and signifies a key milestone in advancing the medical cannabis industry. Akanda aims to strengthen its position in the global market through its UK subsidiary, Canmart, and the Gabriola Green Project in Canada.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.4%
Tags
none
-
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) receives court order to postpone annual shareholder meeting to March 23, 2024, allowing more time for preparations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.07%
Tags
none
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) seeks court approval to extend the deadline for its annual shareholder meeting to facilitate negotiations for the potential sale of a significant portion of its assets. The Company aims to combine the approval of the potential transaction with other annual and special matters to avoid duplication of efforts and expenses.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.3%
Tags
none
-
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) highlights the booming UK cannabis market with a significant increase in medical cannabis imports and patient growth. The UK market has seen substantial growth since the government allowed bulk imports in 2020, making it the second largest market in Europe. Canmart, the Company's UK subsidiary, aims to expand patient access and establish direct sales channels to meet the growing demand.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25.26%
Tags
none
-
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) announced the closing of a registered direct offering, raising approximately $708,000 in gross proceeds. The offering included the sale and issuance of 280,851 common shares and pre-funded warrants to purchase 1,462,991 common shares. Akanda plans to utilize the net proceeds for capital expenditures, operating capacity, working capital, general corporate purposes, and refinancing or repayment of existing indebtedness. The securities were offered under an effective shelf registration statement on Form F-3 and were made available through a prospectus supplement and accompanying base prospectus.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.27%
Tags
Rhea-AI Summary
Akanda Corp. (NASDAQ: AKAN) announces its active monitoring of US federal policy developments regarding the rescheduling and/or descheduling of cannabis under the Controlled Substances Act. The company anticipates potential changes in NASDAQ and NYSE rules, with plans to consolidate US-based operators. The US cannabis industry is projected to grow from $27 billion in 2022 to $50.7 billion by 2028 according to the Brightfield Group.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of AKANDA (AKAN)?

The current stock price of AKANDA (AKAN) is $1.69 as of February 28, 2025.

What is the market cap of AKANDA (AKAN)?

The market cap of AKANDA (AKAN) is approximately 2.4M.

What does Akanda Corp specialize in?

Akanda Corp specializes in the cultivation, manufacturing, and distribution of medical-grade cannabis and wellness products, with a focus on regulatory compliance and innovative technologies.

Where does Akanda operate?

Akanda operates in Europe, primarily in the UK and Portugal, and is expanding into North America and other international markets.

What sets Akanda apart from competitors?

Akanda's differentiators include its EU GMP-certified facilities, strategic partnerships, blockchain and AI-driven innovations, and a comprehensive seed-to-patient supply chain.

How does Akanda use blockchain technology?

Akanda leverages blockchain technology to enhance supply chain transparency, ensuring secure tracking of cannabis products from cultivation to sale.

What is Akanda's role in the UK cannabis market?

Through its subsidiary CanMart Ltd, Akanda is a leading importer and distributor of Cannabis-Based Products for Medicinal Use (CBPMs) in the UK, supplying pharmacies and clinics.

Is Akanda involved in recreational cannabis markets?

While Akanda primarily focuses on medical cannabis, it is exploring opportunities in recreational markets, particularly in Germany and Canada.

What are Akanda's growth strategies?

Akanda's growth strategies include market expansion, technological innovation, strategic partnerships, and acquisitions in key cannabis markets.

What is Akanda's commitment to sustainability?

Akanda emphasizes sustainability through its compliance with EU GMP standards, environmentally friendly practices, and a focus on delivering safe, high-quality products.
AKANDA CORP

Nasdaq:AKAN

AKAN Rankings

AKAN Stock Data

2.38M
1.98M
1.65%
0%
2.19%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
New Romney